[go: up one dir, main page]

ES2090859T3 - Derivados de piridiloxi anti-ulcerosos, su preparacion y usos. - Google Patents

Derivados de piridiloxi anti-ulcerosos, su preparacion y usos.

Info

Publication number
ES2090859T3
ES2090859T3 ES93302221T ES93302221T ES2090859T3 ES 2090859 T3 ES2090859 T3 ES 2090859T3 ES 93302221 T ES93302221 T ES 93302221T ES 93302221 T ES93302221 T ES 93302221T ES 2090859 T3 ES2090859 T3 ES 2090859T3
Authority
ES
Spain
Prior art keywords
group
formula
piridiloxi
ulcerous
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93302221T
Other languages
English (en)
Inventor
Hiroshi Fukumi
Mitsuo Sugiyama
Keiichi Tabata
Koichi Kojima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Application granted granted Critical
Publication of ES2090859T3 publication Critical patent/ES2090859T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cleaning And De-Greasing Of Metallic Materials By Chemical Methods (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)

Abstract

COMPUESTOS DE LA FORMULA (I): [DE DONDE: R1 ES UN GRUPO AMINO CICLICO, O UN GRUPO DIALQUIL AMINO; R2 ES UN GRUPO DE LA FORMULA LOALQUIL, O R2 ES UN GRUPO HETEROCICLICO AROMATICO, O UN GRUPO DE LA FORMULA SUSTITUIDO, O UN GRUPO HETEROCICLICO AROMATICO; B ES UN GRUPO ALQUILIDENO O ALQUILENO; M ES 0,1 O 2; A ES UN GRUPO DE LA FORMULA QUE TIENEN UNA VALIOSA ACTIVIDAD ANTIULCERA.
ES93302221T 1992-03-23 1993-03-23 Derivados de piridiloxi anti-ulcerosos, su preparacion y usos. Expired - Lifetime ES2090859T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP6532492 1992-03-23
JP10139292 1992-04-21
JP17570792 1992-07-02
JP34903592 1992-12-28

Publications (1)

Publication Number Publication Date
ES2090859T3 true ES2090859T3 (es) 1996-10-16

Family

ID=27464571

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93302221T Expired - Lifetime ES2090859T3 (es) 1992-03-23 1993-03-23 Derivados de piridiloxi anti-ulcerosos, su preparacion y usos.

Country Status (19)

Country Link
US (1) US5616579A (es)
EP (1) EP0562833B1 (es)
JP (1) JPH06247933A (es)
CN (1) CN1081437A (es)
AT (1) ATE137748T1 (es)
AU (1) AU659922B2 (es)
CA (1) CA2092111A1 (es)
CZ (1) CZ47493A3 (es)
DE (1) DE69302515T2 (es)
DK (1) DK0562833T3 (es)
ES (1) ES2090859T3 (es)
FI (1) FI931292L (es)
GR (1) GR3020069T3 (es)
HK (1) HK159796A (es)
HU (1) HUT64053A (es)
IL (1) IL105140A (es)
NO (1) NO931041L (es)
NZ (1) NZ247229A (es)
TW (1) TW240222B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1251474B (it) * 1991-09-13 1995-05-15 Mini Ricerca Scient Tecnolog Derivati ossimici ad attivita' fungicida
JP4058129B2 (ja) * 1996-03-18 2008-03-05 株式会社資生堂 ピリジン誘導体及び抗潰瘍剤、抗菌剤

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS568352A (en) * 1979-07-03 1981-01-28 Shionogi & Co Ltd Aminoalkylvenzene derivative
US4300549A (en) * 1980-01-07 1981-11-17 Surgikos Operating room face mask
JPS6185365A (ja) 1984-10-02 1986-04-30 Ikeda Mohandou:Kk アミノアルキルピリジルオキシ誘導体
US4837316A (en) * 1985-08-29 1989-06-06 Fujirebio Kabushiki Kaisha Alkylamide derivatives with H2 -receptor antagonistic and cytoprotective action
JPS63225371A (ja) 1987-03-13 1988-09-20 Fujirebio Inc ピリジルオキシ誘導体
US4912101A (en) * 1987-03-13 1990-03-27 Fujirebio Kabushiki Kaisha 4-aminomethyl-pyridyl-2-oxy derivatives having anti-ulcer activity
JPH0639466B2 (ja) * 1987-08-03 1994-05-25 杏林製薬株式会社 ウレア誘導体
JPH0193247A (ja) * 1987-10-05 1989-04-12 Toshiba Corp マルチノードシステム
JPH0637472B2 (ja) 1988-01-29 1994-05-18 富士レビオ株式会社 ピリジルオキシ誘導体
US5192774A (en) 1988-07-05 1993-03-09 Zeria Pharmaceutical Co., Ltd. Substituted acetamide derivatives, process for their preparation and antiulcer drug containing same
DE69106172D1 (de) * 1990-03-06 1995-02-09 Akzo Nobel Nv Wässrige Hybridpolymerdispersion und Beschichtungszusammensetzung.
JPH04257581A (ja) * 1991-02-08 1992-09-11 Kyorin Pharmaceut Co Ltd ピペリジノメチルピリジン誘導体

Also Published As

Publication number Publication date
JPH06247933A (ja) 1994-09-06
NZ247229A (en) 1994-10-26
FI931292L (fi) 1993-09-24
EP0562833A1 (en) 1993-09-29
TW240222B (es) 1995-02-11
CN1081437A (zh) 1994-02-02
DK0562833T3 (da) 1996-09-09
CA2092111A1 (en) 1993-09-24
NO931041L (no) 1993-09-24
GR3020069T3 (en) 1996-08-31
DE69302515D1 (de) 1996-06-13
DE69302515T2 (de) 1997-01-09
HK159796A (en) 1996-08-30
HUT64053A (en) 1993-11-29
AU659922B2 (en) 1995-06-01
AU3537993A (en) 1993-09-30
NO931041D0 (no) 1993-03-23
IL105140A (en) 1997-01-10
US5616579A (en) 1997-04-01
EP0562833B1 (en) 1996-05-08
IL105140A0 (en) 1993-07-08
ATE137748T1 (de) 1996-05-15
FI931292A0 (fi) 1993-03-23
CZ47493A3 (en) 1993-12-15
HU9300827D0 (en) 1993-06-28

Similar Documents

Publication Publication Date Title
ATE141913T1 (de) Organische salze von n, n'-diacetylcystin
ES2059408T3 (es) Un proceso para la preparacion de un compuesto.
OA09230A (en) "Détection of chemicals by immunoassay".
EG18729A (en) Compound of n- amino - 1,2,4-triazinones used as insecticide.
DE3775527D1 (de) 1,5-diphenylpyrazol-3-carbonsaeurederivate zum schuetzen von kulturpflanzen.
NO904802D0 (no) Fremgangsmaate for fremstilling av aromatiske aminforbindelser.
EP0528858A4 (en) Inhibitors of dipeptidyl-aminopeptidase type iv
BG102162A (en) Substituted (sulpphinic acid, sulphonic acid, sulphonylamino or sulphinylamino)n-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylam ide compounds
ES2053609T3 (es) Derivados de urea inhibidores de lipoxigenasa.
ES2063097T3 (es) Inhibidor de la glicosidasa salbostatina, procedimiento para su preparacion y su empleo.
NO890269L (no) Fremgangsmaate for fremstilling av 1,4-disubstituertepiperidinyl-forbindelser.
IS4367A (is) CCK eða gastrín temprandi 5-heterósýklísk-1,5-bensódíazepín
MX9303933A (es) Compuestos intermedios sinteticos novedosos y procedimiento para la preparacion de los derivados de los aminoacidos.
ZA862484B (en) Peptides
ES2090859T3 (es) Derivados de piridiloxi anti-ulcerosos, su preparacion y usos.
ES2003063A4 (es) Derivados de pirrolidin-2-ona, que tengan actividad nootropica.
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
ATE118763T1 (de) Phenolisches amin als antimelanoma- und depigmentierungsmittel.
DE69008406D1 (de) N-Hydroxycarbyloxy-Derivate von s-Triazinen mit gehinderter Aminogruppe.
NO900969D0 (no) Fremgangsmaate for fremstilling av anilin-derivat.
DE69002136D1 (de) Saccharidderivate von protocatechualdehyd.
NO894516L (no) Fremgangsmaate for fremstilling av 1-aminoalkyl-3-oksosubstituert-4-aryl-1,3,4,5-tetrahydro-2h-1,3-benzodiazepin-2-on, og deres anvendelse som medikamenter.
DE68906449D1 (de) Herstellung von 2,6-dioxopiperidinderivate.
IT1237087B (it) N,n'-di-(trimetossibenzoil) piperazine 2-metossicarbonil sostituite, procedimento per preparare le stesse e composti terapeutici che le contengono.
KR900007857A (ko) 1,4,2-옥사자포스폴리딘-4-아세트산, 2-알콕시-2-옥사이드의 아민염

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 562833

Country of ref document: ES

FG2A Definitive protection

Ref document number: 562833

Country of ref document: ES